(Q44216325)

30 November 2017

title

Mycophenolate mofetil for the prophylaxis of acute graft-versus-host disease in stem cell transplant recipients (English)

1 reference

30 November 2017

9

G Ehninger

1 reference

30 November 2017

4

M Bornhäuser

1 reference

30 November 2017

M G Kiehl

1

1 reference

30 November 2017

K Schäfer-Eckart

2

1 reference

30 November 2017

M Kröger

3

1 reference

30 November 2017

N Basara

5

1 reference

30 November 2017

I W Blau

6

1 reference

30 November 2017

J Kienast

7

1 reference

30 November 2017

A A Fauser

8

1 reference

30 November 2017

V W Armstrong

10

1 reference

30 November 2017

M Shipkova

11

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

Transplantation Proceedings

30 November 2017

published in

1 reference

30 November 2017

volume

34

1 reference

30 November 2017

issue

7

1 reference

30 November 2017

page(s)

2922-2924

1 reference

A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow, Transplantation (EBMT). Chronic Leukaemia Working Party of the EBMT

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903489-9

7 January 2021

Graft-vs.-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903489-9

7 January 2021

Prevention and treatment of acute graft-versus-host disease: the old and the new. A report from the Eastern Cooperative Oncology Group (ECOG).

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903489-9

7 January 2021

A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: an interim report

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903489-9

7 January 2021

Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903489-9

7 January 2021

Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903489-9

7 January 2021

Mycophenolate mofetil and cyclosporine as graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903489-9

7 January 2021

Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903489-9

7 January 2021

Clinical pharmacokinetics of mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903489-9

7 January 2021

The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903489-9

7 January 2021

Opportunities for therapeutic monitoring of mycophenolate mofetil dose in renal transplantation suggested by the pharmacokinetic/pharmacodynamic relationship for mycophenolic acid and suppression of rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903489-9

7 January 2021

Limited sampling strategy for the determination of mycophenolic acid area under the curve in pediatric kidney recipients. German Study Group on MMF Therapy in Pediatric Renal Transplant Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903489-9

7 January 2021

10.1016/S0041-1345(02)03489-9

Identifiers

DOI

1 reference

release_22rtisvnczfndnnu2np3m3eduq

30 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/22rtisvnczfndnnu2np3m3eduq

24 November 2022

mapped directly with Wikidata item

1 reference